Published in Neuroreport on June 26, 2000
Pharmacogenetics of antidepressant response. J Psychiatry Neurosci (2011) 1.28
The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet (2010) 1.04
Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia. Dig Dis Sci (2007) 1.04
G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome. J Neurogastroenterol Motil (2012) 1.04
Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2012) 1.00
Pharmacogenomics: marshalling the human genome to individualise drug therapy. Gut (2003) 0.98
Serotonin transporter and G protein beta 3 subunit gene polymorphisms in Greeks with irritable bowel syndrome. Dig Dis Sci (2011) 0.97
The pattern of expression of guanine nucleotide-binding protein beta3 in the retina is conserved across vertebrate species. Neuroscience (2010) 0.94
From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Can J Psychiatry (2014) 0.93
The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am (2010) 0.92
Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J (2003) 0.88
From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berl) (2004) 0.85
Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol (2007) 0.84
Pharmacogenetics in mood disorder. Curr Opin Psychiatry (2005) 0.84
Biallelic Mutations in GNB3 Cause a Unique Form of Autosomal-Recessive Congenital Stationary Night Blindness. Am J Hum Genet (2016) 0.83
Pharmacogenomics in depression and antidepressants. Dialogues Clin Neurosci (2005) 0.82
Pharmacogenetics of antidepressants. Front Pharmacol (2011) 0.82
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach. BMC Psychiatry (2007) 0.81
Common genetic factors for depression and cardiovascular disease. Dialogues Clin Neurosci (2007) 0.81
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol (2017) 0.79
Association between a functional polymorphism in the renin-angiotensin system and completed suicide. J Neural Transm (Vienna) (2006) 0.79
The C825T Polymorphism of the G-Protein β3 Gene as a Risk Factor for Depression: A Meta-Analysis. PLoS One (2015) 0.79
Common genetic risk factors for psychiatric and simatic disorders. Dialogues Clin Neurosci (2003) 0.79
Association of genetic variants in GNβ3 with functional dyspepsia: a meta-analysis. Dig Dis Sci (2014) 0.78
The GNB3 C825T polymorphism and depression among subjects with alcohol dependence. J Neural Transm (Vienna) (2006) 0.78
Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. J Neural Transm (Vienna) (2006) 0.78
No association of G-protein beta polypeptide 3 polymorphism with irritable bowel syndrome: evidence from a meta-analysis. World J Gastroenterol (2014) 0.78
Gene polymorphisms associated with functional dyspepsia. World J Gastroenterol (2015) 0.77
Genetics and psychopharmacology: prospects for individualized treatment. Essent Psychopharmacol (2005) 0.77
The C825T Polymorphism of the G-Protein β3 Gene as a Risk Factor for Functional Dyspepsia: A Meta-Analysis. Gastroenterol Res Pract (2015) 0.76
GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population. PLoS One (2017) 0.75
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest (1982) 2.23
GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence. J Psychiatr Res (2007) 1.77
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand (2005) 1.67
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry (2004) 1.60
Lyme disease presenting as Tourette's syndrome. Lancet (1998) 1.50
Parentification and its impact on adolescent children of parents with AIDS. Fam Process (1999) 1.50
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry (2002) 1.49
Slippery surfaces of pitcher plants: Nepenthes wax crystals minimize insect attachment via microscopic surface roughness. J Exp Biol (2010) 1.43
Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc Res (1993) 1.43
Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy. Eur J Cancer Prev (2004) 1.41
Regional heterogeneity of cerebral blood flow response to graded volume-controlled hemorrhage. Intensive Care Med (1996) 1.40
Clinical experience with the Greenfield filter in 193 patients and description of a new technique for operative insertion. J Am Coll Surg (1994) 1.40
T-cell subsets and expression of integrins in peripheral blood of patients with migraine. Cephalalgia (1999) 1.40
[Core symptoms of depression. Effectiveness of antidepressant therapy]. Nervenarzt (2009) 1.40
Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry (1998) 1.38
Imaging of cell/substrate contacts of living cells with surface plasmon resonance microscopy. Biophys J (1999) 1.33
Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum (1999) 1.31
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry (2008) 1.20
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett (2001) 1.20
St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry (1998) 1.17
Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis (2006) 1.15
Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res (1999) 1.13
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses (2001) 1.13
Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol (1996) 1.11
The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci (2000) 1.10
Dizziness in an older community dwelling population: a multifactorial syndrome. J Nutr Health Aging (2009) 1.07
Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol (1999) 1.07
Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry (2002) 1.06
Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J (2003) 1.06
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry (2006) 1.04
Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron (1994) 1.04
The SIMA-project: effects of 1 year cognitive and psychomotor training on cognitive abilities of the elderly. Behav Brain Res (1996) 1.03
Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J Neurol (1999) 1.03
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry (1999) 1.01
Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol (1992) 1.01
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett (2001) 1.01
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience (2011) 1.00
Progesterone-induced changes in sleep in male subjects. Am J Physiol (1997) 1.00
Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther (1997) 0.98
Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet (1996) 0.98
Contractile responses to histamine, serotonin, and angiotensin II are impaired by 17 beta-estradiol in human internal mammary arteries in vitro. Pharmacology (1997) 0.98
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification. Eur Psychiatry (2011) 0.97
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry (2003) 0.95
A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry (2003) 0.94
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J Neuroendocrinol (2012) 0.94
The role of immune function in schizophrenia: an overview. Eur Arch Psychiatry Clin Neurosci (1999) 0.94
The frailty syndrome in general practitioner care: a pilot study. Z Gerontol Geriatr (2010) 0.93
Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials. Health Educ Res (2013) 0.93
Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig. Mol Pharmacol (1998) 0.93
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry (2004) 0.93
Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiatry (2000) 0.92
Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics (2001) 0.92
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology (1999) 0.91
Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion. J Clin Psychopharmacol (2000) 0.91
Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur Arch Psychiatry Clin Neurosci (2003) 0.91
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J Biol Psychiatry (2000) 0.91
Neuroactive steroids as modulators of depression and anxiety. Neuroscience (2005) 0.91
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. Am J Psychiatry (2001) 0.91
Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J Neuroendocrinol (2012) 0.91
Increased anti-streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res (2000) 0.91
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Eur Arch Psychiatry Clin Neurosci (2006) 0.90
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology (2001) 0.89
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. J Affect Disord (2011) 0.89
Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur Arch Psychiatry Clin Neurosci (1997) 0.89
Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. Neuropharmacology (2004) 0.89
Psychotropic effects of COX-2 inhibitors--a possible new approach for the treatment of psychiatric disorders. Pharmacopsychiatry (2004) 0.89
Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol (1998) 0.88
Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res (2001) 0.88
Pulmonary haemangiosarcoma with main pulmonary artery thrombosis imitating subacute pulmonary embolism with infarction. Br J Radiol (2004) 0.88
Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res (2000) 0.88
Correlation of micronucleus and apoptosis assays with reproductive cell death can be improved by considering other modes of death. Int J Radiat Biol (2000) 0.88
Association between suicide attempts and 5-HTTLPR-S-allele in alcohol-dependent and control subjects: further evidence from a German alcohol-dependent inpatient sample. Biol Psychiatry (2001) 0.88
Decreased sTNF-RI in migraine patients? Cephalalgia (2003) 0.88